SightfileU.S. market data from official filings

Companies › TYRA

TYRA BIOSCIENCES INC (TYRA)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001863127 · EDGAR filings · Updated 2026-06-26

TYRA BIOSCIENCES INC (TYRA) has reported institutional ownership of 122.4%, with 164 institutional managers holding positions valued at $2.52B per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
122.4%
Institutional managers
164
Reported 13F value
$2.52B
Insider activity
31 trans.
$4.10M net buying
Data flags
1 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, TYRA BIOSCIENCES INC has 164 institutional holders and institutional ownership of 122.4%.

Insider activity

Insiders reported 31 transactions (6 buys, 19 sells) across 9 reporting insiders, with a net reported value of $4.10M.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2022-11-03 (recurring since 2021-11-03) — source filing. The authoritative details are those stated in the filing itself.

Related companies

ARCUS BIOSCIENCES INC COM (RCUS) · ORUKA THERAPEUTICS INC (ORKA) · IMMUNOME INC (IMNM) · PRIVIA HEALTH GROUP INC (PRVA) · NATIONAL VISION HLDGS INC COM (EYE) · DENTSPLY SIRONA INC (XRAY)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-26.